173 related articles for article (PubMed ID: 36111375)
1. Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies.
Hur WS; King KC; Patel YN; Nguyen YV; Wei Z; Yang Y; Juang LJ; Leung J; Kastrup CJ; Wolberg AS; Luyendyk JP; Flick MJ
J Thromb Haemost; 2022 Dec; 20(12):2873-2886. PubMed ID: 36111375
[TBL] [Abstract][Full Text] [Related]
2. Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Poole LG; Pant A; Baker KS; Kopec AK; Cline-Fedewa HM; Iismaa SE; Flick MJ; Luyendyk JP
J Thromb Haemost; 2019 Jan; 17(1):113-125. PubMed ID: 30415489
[TBL] [Abstract][Full Text] [Related]
3. Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte α
Kopec AK; Joshi N; Cline-Fedewa H; Wojcicki AV; Ray JL; Sullivan BP; Froehlich JE; Johnson BF; Flick MJ; Luyendyk JP
J Hepatol; 2017 Apr; 66(4):787-797. PubMed ID: 27965156
[TBL] [Abstract][Full Text] [Related]
4. Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.
Prasad JM; Gorkun OV; Raghu H; Thornton S; Mullins ES; Palumbo JS; Ko YP; Höök M; David T; Coughlin SR; Degen JL; Flick MJ
Blood; 2015 Oct; 126(17):2047-58. PubMed ID: 26228483
[TBL] [Abstract][Full Text] [Related]
5. Thrombin promotes diet-induced obesity through fibrin-driven inflammation.
Kopec AK; Abrahams SR; Thornton S; Palumbo JS; Mullins ES; Divanovic S; Weiler H; Owens AP; Mackman N; Goss A; van Ryn J; Luyendyk JP; Flick MJ
J Clin Invest; 2017 Aug; 127(8):3152-3166. PubMed ID: 28737512
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.
Poole LG; Kopec AK; Groeneveld DJ; Pant A; Baker KS; Cline-Fedewa HM; Flick MJ; Luyendyk JP
Blood; 2021 May; 137(18):2520-2531. PubMed ID: 33569603
[TBL] [Abstract][Full Text] [Related]
7. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.
Flick MJ; LaJeunesse CM; Talmage KE; Witte DP; Palumbo JS; Pinkerton MD; Thornton S; Degen JL
J Clin Invest; 2007 Nov; 117(11):3224-35. PubMed ID: 17932565
[TBL] [Abstract][Full Text] [Related]
8. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
9. Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA.
Juang LJ; Hur WS; Silva LM; Strilchuk AW; Francisco B; Leung J; Robertson MK; Groeneveld DJ; La Prairie B; Chun EM; Cap AP; Luyendyk JP; Palumbo JS; Cullis PR; Bugge TH; Flick MJ; Kastrup CJ
Blood; 2022 Mar; 139(9):1302-1311. PubMed ID: 34958662
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII activity mediates red blood cell retention in venous thrombi.
Aleman MM; Byrnes JR; Wang JG; Tran R; Lam WA; Di Paola J; Mackman N; Degen JL; Flick MJ; Wolberg AS
J Clin Invest; 2014 Aug; 124(8):3590-600. PubMed ID: 24983320
[TBL] [Abstract][Full Text] [Related]
11. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
Achyuthan KE; Mary A; Greenberg CS
J Biol Chem; 1988 Oct; 263(28):14296-301. PubMed ID: 2902081
[TBL] [Abstract][Full Text] [Related]
12. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.
Flick MJ; Du X; Degen JL
Exp Biol Med (Maywood); 2004 Dec; 229(11):1105-10. PubMed ID: 15564436
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor.
Vidal B; Ardite E; Suelves M; Ruiz-Bonilla V; Janué A; Flick MJ; Degen JL; Serrano AL; Muñoz-Cánoves P
Hum Mol Genet; 2012 May; 21(9):1989-2004. PubMed ID: 22381526
[TBL] [Abstract][Full Text] [Related]
14. Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection.
Negrón O; Hur WS; Prasad J; Paul DS; Rowe SE; Degen JL; Abrahams SR; Antoniak S; Conlon BP; Bergmeier W; Hӧӧk M; Flick MJ
PLoS Pathog; 2022 Jan; 18(1):e1010227. PubMed ID: 35041705
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
Xiao Q; Danton MJ; Witte DP; Kowala MC; Valentine MT; Degen JL
J Clin Invest; 1998 Mar; 101(5):1184-94. PubMed ID: 9486990
[TBL] [Abstract][Full Text] [Related]
17. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
[TBL] [Abstract][Full Text] [Related]
18. Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.
Cole HA; Ohba T; Nyman JS; Hirotaka H; Cates JM; Flick MJ; Degen JL; Schoenecker JG
Arthritis Rheumatol; 2014 Aug; 66(8):2222-33. PubMed ID: 24664548
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.
Souri M; Yokoyama C; Osaki T; Ichinose A
Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722
[TBL] [Abstract][Full Text] [Related]
20. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
